Deignan Charles A.

CIK 00016646901 companyALPHARETTA, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001664690

Recent Transactions

38 trades

Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2025-01-08+200,000→ 200,000 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2024-01-19$1.28/sh−12,900→ 384,662 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2024-01-18+200,000→ 200,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2023-09-18+100,000→ 100,000 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2023-09-13$0.40/sh+34,090→ 397,562 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2023-09-13−34,090→ 0 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2023-01-19$1.50/sh−14,030→ 363,472 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2023-01-04+187,500→ 187,500 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-12-20$0.40/sh+23,636→ 377,502 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2022-12-20−23,636→ 0 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-01-19$2.09/sh−8,833→ 351,366 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-01-18+43,750→ 360,199 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-01-18+46,250→ 362,699 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (Right to Buy)
2022-01-18+138,750→ 138,750 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (Right to Buy)
2022-01-18+131,250→ 131,250 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-09-21$6.41/sh−2,800→ 316,449 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-06-21$4.37/sh−2,938→ 319,249 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (Right to Buy)
2021-01-18+195,640→ 195,640 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-01-18+96,360→ 322,187 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2020-06-01$1.88/sh−14,992→ 220,827 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2020-01-08+25,000→ 228,856 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (Right to Buy)
2020-01-08+75,000→ 75,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2019-11-12$1.14/sh+7,500→ 203,856 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2019-09-18+70,000→ 196,356 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2019-05-31+50,000→ 126,356 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2019-03-15$1.36/sh+10,000→ 76,356 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2019-02-05+100,000→ 100,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2018-03-23$11.79/sh+500→ 66,356 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2017-12-08+96,000→ 96,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2017-08-14$7.07/sh+1,000→ 65,309 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2017-06-30$7.74/sh+1,550→ 64,309 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2016-12-15+96,000→ 96,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Employee Stock Option (right to buy)
2016-07-21+30,000→ 30,000 total
Exercise of In-Money
Clearside Biomedical, Inc.$CLSDQ
Warrant to Purchase Common Stock (right to buy)
2016-06-07−470→ 0 total
Exercise of In-Money
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2016-06-07$0.02/sh+470→ 62,761 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2016-06-07$7.00/sh−2→ 62,759 total
Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2016-06-07+4,261→ 62,291 total
Conversion
Clearside Biomedical, Inc.$CLSDQ
Series B Preferred Stock
2016-06-07−9,375→ 0 total

Companies

Clearside Biomedical, Inc.
Chief Financial Officer
$CLSDQ

Recent Filings

Address

C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200

ALPHARETTA, GA, 30005

View on SEC.gov